Caitong International Asset Management’s MapLight Therapeutics MPLT Stock Holding History

Caitong International Asset Management’s Portfolio MPLT Stock Details MPLT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$19.7K	Buy	+550	New	+$15.8K	﹤0.01%	989

Other funds holding MPLT

Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

MSWMA

Market Street Wealth Management Advisors Indianapolis, Indiana $703M AUM 16.2% 1-Year Est. Return

MPW

MA Private Wealth San Carlos, California $671M AUM 23.37% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Caitong International Asset Management's MPLT Position: Q2 2026 in Review

Caitong International Asset Management opened a new position in MapLight Therapeutics (MPLT) in Q2 2026: 550 shares worth $19.7K. The stake represents ﹤0.01% of the portfolio and ranks #989 among its holdings.

19 funds tracked by Wall St. Rank hold MPLT as of Q2 2026.

Caitong International Asset Management held 550 shares of MapLight Therapeutics worth $19.7K as of Q2 2026.
MapLight Therapeutics was a new Caitong International Asset Management position in Q2 2026.
MapLight Therapeutics made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #989 holding.
19 funds tracked by Wall St. Rank held MapLight Therapeutics as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.